Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06926062 · ClinicalTrials.gov registry record · NA

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

A NA study, sponsored by Fred Hutchinson Cancer Center.

Not yet
Registry status
NA
Development phase
1,900
Enrollment target

NCT06926062 is a NA study that has not yet begun recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 1,900 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06926062, a NA study, has not yet begun recruiting, sponsored by Fred Hutchinson Cancer Center.

NOT YET RECRUITING
Registry status
NA
Development phase
1,900 participants
Enrollment target

Study Summary

This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving communication about and recommendations for human papillomavirus (HPV) and other vaccinations in pharmacies. Low HPV vaccination in the United States has placed unvaccinated children at risk of developing cancers as adults that could have been prevented. Pharmacies can be convenient for vaccination because they are open longer hours, have shorter wait times, can see patients without appointments and may cost less. However, many people are not aware that vaccination is available in pharmacies and some pharmacies lack the commitment from staff to vaccinate or may not have protocols in place for vaccination. Proactive communication approaches to recommending HPV vaccination have been shown to be effective in medical offices but have not been tested in the pharmacy setting. Interpersonal communication training incorporates the 5 A's (assess, advice, agree, assist and arrange) behavioral counseling framework to strongly recommend HPV and other vaccines and effectively answer any questions or concerns about vaccination. Vaccination workflow training establishes vaccination decision support strategies that pharmacies use to improve vaccination workflows. Interpersonal communication training and vaccination workflow training alone or in combination may improve communication and recommendations for HPV vaccination and increase HPV vaccination in pharmacies.

Interventions

  • OTHER Best Practice
  • OTHER Educational Intervention

Trial Details

FieldValue
Enrollment Target 1,900 participants
Start Date 2026-06-01
Est. Completion 2027-10-01
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT06926062

The ClinicalTrials.gov registry entry for NCT06926062 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Best Practice is the first listed.

NCT06926062 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06926062 about?

NCT06926062 is a clinical study titled "Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial". This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving communication about and recommendations for human papillomavirus (HPV) and other vaccinations in pharmacies. Low HPV vaccination in the United Sta...

What is the current status of trial NCT06926062?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,900 participants. The study started on 2026-06-01. Estimated completion is 2027-10-01.

What interventions are being tested in trial NCT06926062?

The interventions under investigation include: Best Practice (OTHER), Educational Intervention (OTHER).

Who is sponsoring clinical trial NCT06926062?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.